Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ASCLETIS-PHARMA-INC-46512723/news/Ascletis-Announces-Completion-of-Enrollment-of-120-Patients-in-the-Phase-III-Clinical-Trial-of-FASN-44918146/?utm_source=whatsapp&utm_medium=social&utm_campaign=share